There were few cases of thrombocytopenia associated with levodopa. Herein, we report a patient with Parkinson’s disease, who suffered thrombocytopenia related to long-term use of levodopa.

Citations

Citations to this article as recorded by  

• Acute Thrombocytopenia Likely Induced by Apomorphine: A Case Report
  Clément Martinie De Maisonneuve, Valentin Mira, Romain Muller, Jean‐Philippe Azulay, Guillaume Hache
  Movement Disorders Clinical Practice.2025; 12(1): 94.     CrossRef
• A 70-year-old male exhibiting parkinsonism-hyperpyrexia syndrome during levodopa carbidopa intestinal gel (LCIG) treatment and suspected carbidopa allergy due to positive drug-induced lymphocyte stimulation test (DLST)
  Aya Kawanami, Masanobu Miyashita, Yuichi Miyagi, Kazuko Hasegawa
  Rinsho Shinkeigaku.2024; 64(1): 17.     CrossRef
• Dysregulated Coagulation in Parkinson’s Disease
  Xinqing Wang, Wenxin Li, Xinyue Zhao, Ning Hu, Xi Wang, Xilin Xiao, Kai Yang, Taolei Sun
  Cells.2024; 13(22): 1874.     CrossRef
• High rates of blood transfusion associated with Parkinson’s disease
  Shane Shahrestani, Julian Gendreau, Ali R. Tafreshi, Nolan J. Brown, Khashayar Dashtipour
  Neurological Sciences.2022; 43(8): 4761.     CrossRef
• Platelet abnormalities in patients with Parkinson's disease undergoing preoperative evaluation for deep brain stimulation
  Sheng-Che Chou, Chun-Hwei Tai, Sheng-Hong Tseng
  Scientific Reports.2022;[Epub]     CrossRef
• Levodopa Plus Occlusion Therapy versus Occlusion Therapy Alone for Children with Anisometropic Amblyopia
  Majid Farvardin, Mohammad Reza Khalili, Mehdi Behnia
  Journal of Ophthalmic and Vision Research.2019;[Epub]     CrossRef